There are some key clinical and financial use cases already showing their worth – but while innovation around artificial intelligence is happening rapidly, there's risk in moving too quickly, one ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...